Cryosite Limited
Cryosite Limited
- P/E ratio
- 26.64
Your view on CTE.AX
Overview
What the company does, where it operates, and who runs it.
About Cryosite Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Jane Hao
- Headquarters
- 13a Ferndell Street, South Granville, NSW, AU
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Jane Hao
- Headquarters
- 13a Ferndell Street, South Granville, NSW, AU
Cryosite Limited, founded in 1999 and headquartered in South Granville, Australia, specializes in providing outsourced logistics and storage solutions to the life sciences industry within Australia. The company operates through two distinct divisions.
Its Clinical Trials and Biological Services Logistics segment offers comprehensive support to the clinical research and pharmaceutical sectors, encompassing services such as specialized temperature-controlled and general biological storage, precise labeling, secondary packaging, and end-to-end supply chain management capabilities like scheduled drug distribution, returns processing, material destruction, status oversight, comparator sourcing, and validated import/export and transportation.
The second division, Cord Blood and Tissues Storage, focuses on the long-term cryogenic preservation of cord blood and tissue samples. Cryosite's client base spans the research, medical, pharmaceutical, veterinary, and biotechnology industries.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Cryosite Limited. Starting points for Cryosite Limited: P/E 26.6, EPS AUD 0.05, beta 0.16 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Cryosite Limited. Cryosite Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Cryosite Limited. Trailing twelve-month EPS for Cryosite Limited stands at AUD 0.05. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.03 | AUD 0.03 | AUD 0.05 | AUD 0.06 |
| Lowest estimate | AUD 0.03 | AUD 0.03 | AUD 0.05 | AUD 0.06 |
| Highest estimate | AUD 0.03 | AUD 0.03 | AUD 0.05 | AUD 0.06 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | — | — | — | — |
| Growth vs a year ago | — | — | — | — |
Revenue estimates
| Total | This quarterDec 2026 | Next quarterJun 2027 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 9.20M | AUD 9.60M | AUD 18.80M | AUD 20.20M |
| Lowest estimate | AUD 9.20M | AUD 9.60M | AUD 18.80M | AUD 20.20M |
| Highest estimate | AUD 9.20M | AUD 9.60M | AUD 18.80M | AUD 20.20M |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | — | — | — | — |
| Growth vs a year ago | — | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Cryosite Limited. Cryosite Limited has reported as a listed company since 2002. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| BDX.AXBCAL Diagnostics Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| CMP.AXCompumedics Limited | Healthcare | Medical - Devices | — | ||
| GSS.AXGenetic Signatures Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IBX.AXImagion Biosystems Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IDX.AXIntegral Diagnostics Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IIQ.AXINOVIQ Ltd | Healthcare | Medical - Diagnostics & Research | — | ||
| MAP.AXMicroba Life Sciences Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| NUZ.AXNeurizon Therapeutics Limited | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| ILMNIllumina, Inc. | Healthcare | NASDAQ | $31.8B | ||
| IMDXInsight Molecular Diagnostics Inc. | Healthcare | NASDAQ | $52.1M | ||
| IME.AXImExHS Limited | Healthcare | ASX | — | ||
| IMMVFImmunovia AB (publ) | Healthcare | OTC | $6.1M | ||
| IQVIQVIA Holdings Inc. | Healthcare | NYSE | $42.5B | ||
| ISPCiSpecimen Inc. | Healthcare | NASDAQ | $1.3M | ||
| IVROInVitro International | Healthcare | OTC | $1.8M | ||
| IZO.CNIzotropic Corporation | Healthcare | CNQ | $20.6M | ||
| IZOZFIzotropic Corporation | Healthcare | OTC | $11.9M | ||
| JMPHFLeveljump Healthcare Corp. | Healthcare | OTC | $15.2M | ||
| LDDDLongduoduo Company Limited | Healthcare | OTC | $15.3M | ||
| LHLabcorp Holdings Inc. | Healthcare | NYSE | $30.1B | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Cryosite Limited. Coverage tracks Cryosite Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Cryosite Limited.